Momentum investing is still the dominant factor in biotech. Many companies have not participated in the rallies but the "story" stocks have kept things moving even with the more recent pullback.
Topics included:
Tabloids and Cancer
Momentum in Biotech
Reversion to the Mean
Follow-On Investing
2Q Insights and Outlooks
Comentários